Teladoc Health (TDOC) Research & Development (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Research & Development data on file, last reported at $67.9 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 2.99% year-over-year to $67.9 million; the trailing twelve-month figure through Mar 2026 stood at $275.8 million (down 6.77% YoY), and the FY2025 full-year result was $277.9 million, down 9.55% from the prior year.
• Research & Development retreated to $67.9 million in Q1 2026, from $71.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $89.9 million in Q4 2023 to a low of $67.6 million in Q3 2025.
• A 5-year average of $78.5 million and a median of $78.7 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development grew 13.81% in 2022 and slipped 14.66% in 2024, its largest moves.
• Tracing TDOC's Research & Development over 5 years: stood at $82.9 million in 2022, then climbed by 8.45% to $89.9 million in 2023, then retreated by 14.66% to $76.8 million in 2024, then slipped by 6.7% to $71.6 million in 2025, then slipped by 5.23% to $67.9 million in 2026.
• Business Quant data shows TDOC's Research & Development at $67.9 million in Q1 2026, $71.6 million in Q4 2025, and $67.6 million in Q3 2025.